Bank Pictet & Cie (Europe)’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,597
Closed -$380K 192
2024
Q4
$380K Sell
4,597
-621
-12% -$49K 0.01% 140
2024
Q3
$373K Sell
5,218
-4,286
-45% -$303K 0.01% 126
2024
Q2
$651K Buy
9,504
+768
+9% +$45.9K 0.02% 113
2024
Q1
$469K Buy
8,736
+3,259
+60% +$175K 0.01% 135
2023
Q4
$292K Sell
5,477
-211
-4% -$10.3K 0.01% 231
2023
Q3
$282K Buy
+5,688
New +$318K 0.01% 222
2023
Q1
Sell
-20,668
Closed -$1.54M 177
2022
Q4
$1.54M Sell
20,668
-1,591
-7% -$108K 0.08% 94
2022
Q3
$1.33M Sell
22,259
-234
-1% -$14.1K 0.07% 95
2022
Q2
$1.26M Sell
22,493
-20,853
-48% -$1.37M 0.06% 92
2022
Q1
$3.2M Buy
43,346
+35
+0.1% +$2.43K 0.12% 76
2021
Q4
$3.13M Buy
43,311
+10,802
+33% +$784K 0.11% 79
2021
Q3
$2.49M Buy
32,509
+24,283
+295% +$1.95M 0.09% 84
2021
Q2
$638K Sell
8,226
-71,433
-90% -$5.08M 0.02% 122
2021
Q1
$4.91M Buy
+79,659
New +$5.04M 0.2% 69

Other funds holding GMED

Bank Pictet & Cie (Europe)'s GMED Position: Q1 2025 in Review

Bank Pictet & Cie (Europe) sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 4,597 shares — an estimated $380K sold.

Bank Pictet & Cie (Europe) first reported a position in GMED in Q1 2021 and held it in 14 quarters. The position peaked at $4.91M in Q1 2021. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

  • Bank Pictet & Cie (Europe) reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 4,597 Globus Medical shares in Q1 2025, an estimated $380K.
  • Bank Pictet & Cie (Europe) first reported a position in Globus Medical in Q1 2021 and held it in 14 quarters.
  • Bank Pictet & Cie (Europe)'s Globus Medical position peaked at $4.91M in Q1 2021.
  • 514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2025, filed 17 Apr 2025.